Kate Hardey

Kate Hardey is a corporate healthcare partner at Kirkland & Ellis LLP, based in the Washington, D.C. office.12 She is an experienced attorney with a focus on a broad range of healthcare transactions and regulatory matters.12

Professional Background

Kate has extensive experience in various aspects of healthcare law:

• Healthcare transaction diligence risk analysis
• Structuring and negotiation of leveraged finance transactions
• Fraud and abuse / Corporate Compliance
• U.S. Food and Drug Administration (FDA) regulatory matters
• Pharmaceutical and medical device sales and marketing compliance
• Hospital regulatory compliance and Board Governance
• Health Insurance Portability and Accountability Act (HIPAA) Compliance
• Medicare and Medicaid reimbursement1

Career History

Before joining Kirkland & Ellis in July 2023, Kate held several notable positions:

• Partner at McGuireWoods LLP (December 2015 - July 2023)
• Senior Counsel - Healthcare Regulatory at GE Capital (May 2013 - December 2015)
• Hospital Counsel at MedStar Health (September 2011 - May 2013)
• Associate at McDermott Will & Emery LLP (July 2008 - August 2011)
• Associate, Health Care at Hogan Lovells (June 2004 - July 2008)
• Associate at JONES DAY® (May 2002 - May 2004)1

Education

Kate holds the following degrees:

• J.D. from Catholic University of America (cum laude)
• M.S. in Healthcare Administration from Marymount University
• B.A. in English from George Mason University2

Recognition

Kate has received several accolades throughout her career:

• Recognized as a "Most Effective Deal-Maker" by American Lawyer Media in June 2023
• Named one of the "Leaders in the Law" by North Carolina Lawyers Weekly in November 2020
• Received the M&A Advisor award for Healthcare/Life Sciences Deal of the Year in September 20222

Kate Hardey is known for her deep understanding of the complex regulatory landscape affecting companies in the healthcare provider and life science space.2 She is regularly called upon to advise on large corporate transactions in connection with major acquisitions and mergers undertaken by private equity and strategic acquirers in the healthcare provider, healthcare services, and life sciences platforms.2